AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Edmund Mickunas named VP regulatory and clinical affairs.
2004 OCT 18 - (NewsRx.com & NewsRx.net) -- Oragenics, Inc., (ONI) has named Edmund Mickunas vice president, regulatory and clinical affairs.
"We are very fortunate to find someone with Ed Mickunas' more than 20 years experience in regulatory affairs and clinical trials management within the biotechnology and pharmaceutical industries," said Chuck Soponis, Oragenics CEO. "His experience covers a broad range of regulatory and compliance issues in both the United States and Europe, as well as specific expertise in the area of dental products. I am pleased to welcome Ed to the Oragenics management team."
Prior to joining Oragenics, Mickunas was an independent consultant offering professional services in the areas of ...
- Examine Pharma Business Management in India as the Pharmia Industry Market is...
- Press release article from: M2 Presswire February 4, 2009 700+ words
...Research and Markets: Examine Pharma Business Management in India as the Pharmia...researchandmarkets.com/research/46a25f/pharma_business_ma) has announced the addition of the "Pharma Business Management in India" report to...
- Examine Pharma Business Management in India as the Pharma Industry Market is...
- Newspaper article from: Biotech Week February 18, 2009 700+ words
...researchandmarkets.com/research/ef9e33/pharma_business_ma) has announced the addition of the "Pharma Business Management in India" report to...come out with the report titled Pharma Business Management Insight for which an...
- Research and Markets: Examine Pharma Business Management in India as the Pharma...
- Press release article from: Business Wire February 5, 2009 700+ words
...researchandmarkets.com/research/ef9e33/pharma_business_ma) has announced the addition of the "Pharma Business Management in India" report to...come out with the report titled Pharma Business Management Insight for which an...
- Pharma business sold for $6.9 billion -- "BASF to focus more strongly on...
- Press release article from: M2 Presswire December 15, 2000 700+ words
M2 PRESSWIRE-15 December 2000-BASF: Pharma business sold for $6.9 billion -- "BASF to focus more strongly...agricultural products and oil and gas." After the sale of its pharma business, BASF will generate more than half of its sales in...
- Pharma Business sold for $6.9 Billion: "BASF to Foucs More Strongly on...
- Press release article from: Business Wire December 15, 2000 700+ words
...presence. This is being supplemented by a growing position in agricultural products and oil and gas." After the sale of its pharma business, BASF will generate more than half of its sales in cyclically resilient operations. BASF achieves more than two-thirds...
- Lupin acquires pharma business of Rubamin.
- News wire article from: PTI - The Press Trust of India Ltd. September 27, 2007 700+ words
Lupin acquires pharma business of Rubamin Mumbai, Sep 27 (PTI) -- Drug maker Lupin Ltd today said it has acquired the pharmaceutical business of Rubamin group...
- The Cambrex pharma business unit at Cambrex Corp. (Jobs and People).(hires...
- Magazine article from: Chemical Market Reporter July 21, 2003 700+ words
Richard D. Giles Richard D. Giles has been appointed director of business development for the Cambrex pharma business unit at Cambrex Corp. Prior to joining the company, Mr. Giles spent eight years with Chattem Chemicals Inc., where he was...
- 2nd Annual Pharma Business Intelligence Summit September 19-20 at the Sheraton...
- Press release article from: PR Newswire July 16, 2002 700+ words
NEW YORK -- The 2nd Annual Pharma Business Intelligence Summit will be presented by the Strategic Research Institute September 19-20 at the Sheraton Woodbridge Place in...
